iNeo-Vac-P01
- Generic Name
- iNeo-Vac-P01
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection
Phase 1
Recruiting
- Conditions
- Resectable Esophageal Cancer
- Interventions
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Target Recruit Count
- 40
- Registration Number
- NCT05307835
- Locations
- 🇨🇳
The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath